58
13.73% (24h)
Lite Strategy
Clinical-stage pharmaceutical company(NASDAQ: LITS)
64%
Transparency Score 
Analytics
Performances
Comparison
Essentials
Details
Event Calendar
News
Related News
𝕏 Data
Follow Updates
Follow Lists
Performances
RD Popularity Index
Project Rank: 1246/19116
RD Growth Index
--
Project Rank: --/19116
Comparison
Total Raised: --
Fundraising not disclosed
FDV: --
Token not listed
24h Trading Volume: --
Token not listed
Project Name
Intro
--
Total Raised
--
Core Team
--
Core Investors
--
RD Growth Index (7d %)
--
RD Popularity Index (7d %)
--
Details
Lite Strategy, Inc.(NASDAQ: LITS) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.
Event Calendar
Share to 
Share poster
Share poster𝕏 Follow Updates
No Data𝕏 Follow Lists
Rate Lite Strategy
Rated by 0 users
What’s your take on Lite Strategy? Share your review.
Reviews and ratings are posted by users, do not constitute financial advice, and do not represent the views of the platform.
Similar Projects
Mega Matrix Inc.
US-listed companies focusing on blockchain finance and digital content(NYSE American: MPU)
Bitcoin Group SE
Acquisition Portfolio Companies (ADE.DE)
Ming Shing Group
Wet trades works services company(NAQ: MSW)
Anap Holdings Inc.
Japanese apparel retailer(3189.T)
SenseTime Group Limited
AI Technology Company (HKEX: 0020.HK)
